Treatments. Chronic eosinophilic leukemia is rare and can develop differently in different people. It can be stable for many years and then quickly change into AML. As a result, there is no standard treatment plan for chronic eosinophilic leukemia.

What is considered high eosinophil count?

A count of more than 500 eosinophils per microliter of blood is generally considered eosinophilia in adults. A count of more than 1,500 eosinophils per microliter of blood that lasts for several months is called hypereosinophilia.

What causes chronic eosinophilic leukemia?

Chronic eosinophilic leukemia is a subtype of clonal eosinophilia, meaning it is caused by a new genetic mutation or change in the blood cells. It is sometimes called hypereosinophilic syndrome (HES). This disease is classified as a myeloproliferative neoplasm (MPN).

What is eosinophilic leukemia and how is it treated?

Eosinophilic leukemia is a blood cancer that affects eosinophils (a type of white blood cell). Eosinophils are a part of the immune system. They help the body fight infections from bacteria and parasites, kill old or damaged cells, and play a role in allergic reactions. Eosinophilic leukemia can be acute (fast-growing) or chronic (slow-growing).

What is chronic eosinophilic leukemia (MPN)?

This disease is classified as a myeloproliferative neoplasm (MPN). Myelo- means bone marrow and proliferative means too much blood cell growth. This section focuses on chronic eosinophilic leukemia. Acute eosinophilic leukemia is very rare and is treated similarly to acute myeloid leukemia (AML).

What is eosinophilia and what causes it?

Eosinophilia is a condition that develops when the bone marrow makes too many eosinophils, a type of white blood cell. People can have many eosinophils without having leukemia.

Which immunophenotypes are associated with eosinophilic leukemia?

Fibrosis (caused by the degranulation and release of eosinophilic basic and cationic proteins) No specific immunophenotype has been associated with chronic eosinophilic leukemia, not otherwise specified; however, immunophenotyping is important to exclude T lymphocyte driven eosinophilia or acute leukemia